Skip to main content
Top

Supportive Care in Cancer

Issue 3/2005

Content (15 Articles)

Editorial

New directions in supportive care

Steven M. Grunberg

Review Article

Advances in opioid therapy and formulations

Declan Walsh

Review Article

Contribution to variability in response to opioids

Geoffrey W. Hanks, Colette Reid

Review Article

Advances in opioid pharmacology

Geoffrey K. Gourlay

Original Article

Symptoms, treatment and “dying peacefully” in terminally ill cancer patients: a prospective study

Jean-Jacques Georges, Bregje D. Onwuteaka-Philipsen, Agnes van der Heide, Gerrit van der Wal, Paul J. van der Maas

Original Article

Nutritional status of cancer patients and its relationship to function in an inpatient rehabilitation setting

Ying Guo, J. Lynn Palmer, Guddi Kaur, Susan Hainley, Beth Young, Eduardo Bruera

Original Paper

Outcome research in palliative care: could it represent a new dimension of clinical research or clinical practice?

Davide Tassinari, Marco Maltoni, Sergio Sartori, Manuela Fantini, Barbara Poggi, Alberto Ravaioli

Original Article

Administration of recombinant human erythropoietin alpha before autologous stem cell transplantation reduces transfusion requirement in multiple myeloma patients

Massimo Martino, Esther Oliva, Giuseppe Console, Caterina Stelitano, Mohamed Fujo, Giuseppe Messina, Giuseppe Irrera, Giulia Pucci, Rosalba Mandaglio, Vincenzo Callea, Francesco Nobile, Pasquale Iacopino, Fortunato Morabito

Original Article

Successful use of ketamine for intractable cancer pain

Dominique A. Lossignol, Myriam Obiols-Portis, Jean-Jacques Body

Short Communication

Oral administration of vinorelbine can overcome intractable endovenous-vinorelbine-associated acute tumor pain

T. De Pas, A. Sbanotto, C. Catania, M.G. Banfi, G. Curigliano, F. Nolè, N. Fazio, V. Formica, G. Veronesi, F. de Braud

Short Communication

Thyrotoxic crisis induced by cytotoxic chemotherapy

Khalid A. Al-Anazi, Sohail Inam, M. T. Jeha, R. Judzewitch

Letter to the Editor

Letter to the Editor

Meagan Doyle, Elizabeth A. Barnes, Emily Sinclair, Cyril Danjoux, Edward Chow

Letter to the Editor

Radiotherapy, morphine, and bone pain: a difficult relationship?

Alberto Sbanotto, Maria Banfi, Daniela Alterio, Andrea Rocca

Letter to the Editor

Reply to the comment of Dr. Sbanotto

Hiromichi Ishiyama

Forthcoming Meetings

Forthcoming Meetings March 2005

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine